OSCR

Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances.

Overview

Authors: Dezhen Tu1,2, Yuxiao Zheng2,3, Pingping Ding2, Miao Shen3, Wangyang Tang3, Bin Wei4, Hongyan Wang2,3
  1. Innovative Institute of Tumor Immunity and Medicine, Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022 China
  2. State Key Laboratory of Cell Biology & Key Laboratory of RNA Science and Engineering, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031 China
  3. Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024 China
  4. Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032 China
Journal: Molecular neurodegeneration, volume 21, issue 1, article 40
Dates: received 19 January 2026; accepted 12 May 2026; published online 28 May 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.1186/s13024-026-00951-3 · PMID 42204590 · PMCID PMC13403443 · OpenAlex W7162565740
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), other condition (population), cellular / molecular (subfield)
Methods: Spectral & time-frequency
Keywords: Cholesterol metabolism, Neurodegeneration, Microglia, Neuron, Astrocyte, Oligodendrocyte
MeSH: Cholesterol*, Neurodegenerative Diseases*, Animals, Brain, Humans, Neurosteroids, Protein Aggregates (* major topic)
Topic: Cholesterol and Lipid Metabolism (Biochemistry, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 257 references in the paper

Abstract

Cholesterol metabolites are abundant in the central nervous system (CNS) that regulate cell membrane fluidity, signal transduction, and inter- and intracellular vesicular transport, as well as cell proliferation/cell death or migration. Brain cholesterol synthesis and metabolism are tightly coupled to the functional homeostasis of neurons, glial cells or microglia, and dysregulation of these processes has been strongly implicated in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). This review provides a comprehensive overview of how cholesterol synthesis, esterification, efflux, uptake, and oxidation affect the CNS function, highlighting the function of key enzymes or metabolites in distinct brain cell types during neurodegeneration. Based on single-cell/nucleus RNA sequencing data from the brains of AD, PD, and HD patients, we summarize cell-type-specific genes in cholesterol metabolism pathways, shedding new light to understand cellular heterogeneity. The role of cholesterol-derived neurosteroids in neurodegenerative diseases is also discussed. Furthermore, how cholesterol metabolites modulate the formation, aggregation, and degradation of amyloid-β (Aβ), α-synuclein and huntingtin, as well as Tau protein phosphorylation are outlined. Finally, future research directions are proposed that aim to understand neurodegenerative diseases with new angle.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

Not applicable.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 6 keywords, 7 MeSH terms, 254 references.

Cite

This paper

Tu, D., Zheng, Y., Ding, P., Shen, M., Tang, W., Wei, B., & Wang, H. (2026). Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances. Molecular neurodegeneration, 21(1), 40. https://doi.org/10.1186/s13024-026-00951-3

BibTeX

@article{tu2026cholesterol,
author = {Tu, Dezhen and Zheng, Yuxiao and Ding, Pingping and Shen, Miao and Tang, Wangyang and Wei, Bin and Wang, Hongyan},
title = {{Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances}},
journal = {Molecular neurodegeneration},
year = {2026},
month = may,
volume = {21},
number = {1},
pages = {40},
publisher = {BMC},
issn = {1750-1326},
doi = {10.1186/s13024-026-00951-3},
url = {https://doi.org/10.1186/s13024-026-00951-3},
pmid = {42204590},
pmcid = {PMC13403443}
}

RIS

TY - JOUR
AU - Tu, Dezhen
AU - Zheng, Yuxiao
AU - Ding, Pingping
AU - Shen, Miao
AU - Tang, Wangyang
AU - Wei, Bin
AU - Wang, Hongyan
TI - Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances
T2 - Molecular neurodegeneration
J2 - Mol Neurodegener
PY - 2026
DA - 2026/05/28
VL - 21
IS - 1
SP - 40
SN - 1750-1326
PB - BMC
DO - 10.1186/s13024-026-00951-3
UR - https://doi.org/10.1186/s13024-026-00951-3
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s13024-026-00951-3",
"type": "article-journal",
"title": "Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances",
"container-title": "Molecular neurodegeneration",
"author": [
{
"family": "Tu",
"given": "Dezhen"
},
{
"family": "Zheng",
"given": "Yuxiao"
},
{
"family": "Ding",
"given": "Pingping"
},
{
"family": "Shen",
"given": "Miao"
},
{
"family": "Tang",
"given": "Wangyang"
},
{
"family": "Wei",
"given": "Bin"
},
{
"family": "Wang",
"given": "Hongyan"
}
],
"container-title-short": "Mol Neurodegener",
"volume": "21",
"issue": "1",
"page": "40",
"DOI": "10.1186/s13024-026-00951-3",
"PMID": "42204590",
"PMCID": "PMC13403443",
"ISSN": "1750-1326",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s13024-026-00951-3",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
28
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13024-022-00566-4
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Journal: Molecular neurodegeneration
In common: other condition, cellular / molecular, 17 references
[2] doi:10.1186/s40478-025-02054-4
Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's disease.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 13 references
[3] doi:10.1038/s41467-026-68937-9
Gut microbiota-dependent 24-hydroxycholesterol metabolism contributes to capsaicin-induced amelioration of Alzheimer's disease-like pathology in mice.
Journal: Nature communications
In common: cellular / molecular, 9 references
[4] doi:10.1038/s42255-025-01365-z [code]
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases.
Journal: Nature metabolism
In common: other condition, cellular / molecular, 8 references
[5] doi:10.1002/advs.202519874
Neuronal Cholesterol Deficiency Mediated by Astrocytic SREBP2 Downregulation Leads to Postoperative Cognitive Dysfunction Through Impairment of Hippocampal Synaptic Plasticity and Excitatory Synaptic Transmission.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: cellular / molecular, 7 references
[6] doi:10.1016/j.jlr.2024.100555
Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz.
Journal: Journal of lipid research
In common: 7 references
[7] doi:10.1016/j.jlr.2025.100952 [code]
Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation.
Journal: Journal of lipid research
In common: cellular / molecular, 7 references
[8] doi:10.3389/fendo.2023.1286931
Allopregnanolone pleiotropic action in neurons and astrocytes: calcium signaling as a unifying mechanism.
Journal: Frontiers in endocrinology
In common: cellular / molecular, 6 references
[9] doi:10.1016/j.xcrm.2023.101278 [code]
Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis.
Journal: Cell reports. Medicine
In common: other condition, cellular / molecular, 6 references
[10] doi:10.3389/fnins.2021.778822
Synapses, Microglia, and Lipids in Alzheimer's Disease.
Journal: Frontiers in neuroscience
In common: cellular / molecular, 7 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.